Here’s whether LifeStance Health Group, Inc. Common Stock (LFST) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+7.64% over 10 days); strong 1-year return of +122.6%; 3-month momentum positive (+62.4%); rising volume confirms the move (1.49x 30d avg). Currently 2.6% off its 52-week high. Score: +7/7.
LFST is in a confirmed uptrend, trading above both its 50-day ($10.28) and 200-day ($7.72) moving averages. An RSI of 67.3 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +122.6% compares to +20.4% for SPY (beat the market by 102.2%).
$10,000 invested 1 year ago→ $22,258 today
vs. S&P 500 (SPY) — same period beat market by 102.2%